default author photo

Jolien Tol

Jeroen Bosch Hospital

Netherlands

  • Jeroen Bosch Hospital

SCHOLARLY PAPERS

2

DOWNLOADS

188

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Overall Survival of Patients with De Novo HER2-Positive Metastatic Breast Cancer in the Netherlands from 2008 to 2017: A Population-Based Cohort Study

Downloads 166 (456,852)

Overall Survival of Patients with De Novo HER2-Positive Metastatic Breast Cancer in the Netherlands from 2008 to 2017: A Population-Based Cohort Study

Number of pages: 29 Posted: 06 Feb 2025
Nan Ding, Karlijn E.P.E. Hermans, Thiemo J.A. van Nijnatten, Sanne M.E. Engelen, Jolien Tol, Loes Kooreman, Marie-Jeanne T.F.D. Vrancken Peeters, Sabine Siesling, Adri C. Voogd, Vivianne C.G. Tjan-Heijnen and Sandra M.E. Geurts
Maastricht University, Maastricht University, Maastricht University - Department of Radiology and Nuclear Medicine, Maastricht University - Department of Surgery, Jeroen Bosch Hospital, Maastricht University, Netherlands Cancer Institute Antoni van Leeuwenhoek, Netherlands Comprehensive Cancer Organisation, Maastricht University, Maastricht University and Maastricht University
Downloads 106 (668,983)

Abstract:

Loading...

Neoplasms Metastasis, HER2, Survival Analysis, Pertuzumab, Cohort Study

Overall Survival of Patients with de novo HER2-Positive Metastatic Breast Cancer in the Netherlands from 2008 to 2017: A Population-Based Cohort Study

Number of pages: 28 Posted: 20 Feb 2025
Nan Ding, Karlijn E.P.E. Hermans, Thiemo J.A. van Nijnatten, Sanne M.E. Engelen, Jolien Tol, Loes Kooreman, Marie-Jeanne T.F.D. Vrancken Peeters, Sabine Siesling, Adri C. Voogd, Vivianne C.G. Tjan-Heijnen and Sandra M.E. Geurts
Maastricht University, Maastricht University, Maastricht University - Department of Radiology and Nuclear Medicine, Maastricht University - Department of Surgery, Jeroen Bosch Hospital, Maastricht University, Netherlands Cancer Institute Antoni van Leeuwenhoek, Netherlands Comprehensive Cancer Organisation, Maastricht University, Maastricht University and Maastricht University
Downloads 60 (986,385)

Abstract:

Loading...

Neoplasms metastasis, HER2, Survival Analysis, pertuzumab, Cohort Study

2.

Receptor Discordance During the Treatment Course of Patients with Metastatic Breast Cancer: Results from the Sonabre Registry

Number of pages: 25 Posted: 02 May 2025
Karlijn E.P.E. Hermans, Sandra M.E. Geurts, Franchette W.P.J. van den Berkmortel, Jolien Tol, Joan Heijns, Marcus W. Dercksen, Birgit E.P.J. Vriens, Kirsten N.A. Aaldering, Manon J.A.E. Pepels, Natascha A. J. B. Peters, Linda van de Winkel, Eline Boon, Nathalie Teeuwen, Maartje A.C.E. van Kats and Vivianne C.G. Tjan-Heijnen
Maastricht University, Maastricht University, Zuyderland Medical Centre, Jeroen Bosch Hospital, Amphia Hospital, affiliation not provided to SSRN, Catharina Hospital, affiliation not provided to SSRN, Elkerliek Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and Maastricht University
Downloads 22 (1,436,435)

Abstract:

Loading...

breast neoplasms, neoplasm metastasis, biopsy, Receptor, Estrogen, Receptor, Progesterone, Receptor, ErbB-2